Hudson Bay Capital Management
HUMA icon

Hudson Bay Capital Management’s Humacyte HUMA Stock Holding History

Hudson Bay Capital Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$293K Buy
+375,000
New +$348K ﹤0.01% 1068
2021
Q1 		– Sell
-200,000
Closed -$2.01M – 894
2020
Q4 		$2.01M Buy
+200,000
New +$1.98M 0.02% 384

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Hudson Bay Capital Management's HUMA Position: Q2 2026 in Review

Hudson Bay Capital Management opened a new position in Humacyte (HUMA) in Q2 2026: 375,000 shares worth $293K. The stake represents ﹤0.01% of the portfolio and ranks #1068 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in HUMA as recently as Q4 2020.

Hudson Bay Capital Management first reported a position in HUMA in Q4 2020 and has held it in 2 quarters since. The position peaked at $2.01M in Q4 2020. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Hudson Bay Capital Management held 375,000 shares of Humacyte worth $293K as of Q2 2026.
  • Humacyte was a new Hudson Bay Capital Management position in Q2 2026.
  • Humacyte made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #1068 holding.
  • Hudson Bay Capital Management first reported a position in Humacyte in Q4 2020 and has held it in 2 quarters since.
  • Hudson Bay Capital Management's Humacyte position peaked at $2.01M in Q4 2020.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.